WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD | Market Cap | 1.06B -19.6% |
| Revenue (ttm) | 1.52B +35.6% |
| Net Income | 3.77M |
| EPS | 0.01 |
| Shares Out | 255.95M |
| PE Ratio | 279.62 |
| Forward PE | 14.92 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 798,927 |
| Open | 4.180 |
| Previous Close | 4.180 |
| Day's Range | 4.095 - 4.250 |
| 52-Week Range | 3.580 - 5.340 |
| Beta | 1.21 |
| Analysts | Strong Buy |
| Price Target | 7.21 (+74.16%) |
| Est. Earnings | Nov 6, 2026 |
About WELL Health Technologies
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women’s health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates prac... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 14 analysts, the average rating for WELL stock is "Strong Buy." The 12-month stock price target is $7.21, which is an increase of 74.16% from the latest price.
News
WELL Health to Present at The Cantech Investment Conference on October 8 in Toronto
WELL Presentation Time: 9:00 AM ET in Track 1. Vancouver, British Columbia--(Newsfile Corp. - October 2, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a ...
WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health...
WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement
WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 issuer, subject to satisfaction of the TSXV's customary listing conditions, and is expected to commence trading on ...
WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network
WELL Research is the clinical research brand of WELL Health Technologies. WELL Research offers the unique combination of full-service contract research organization (CRO) services in early-phase trial...
WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer
WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles a...
HEALWELL's DARWEN(TM) to Power AI-Driven Clinical Trial Matching for WELLTRUST(TM), a Network of Over 100,000 Consented Patients
HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching ...
WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents
WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to ...
WELL Health Redeems $70 Million 5.50% Convertible Debentures
WELL Health redeemed early all of its outstanding 5.50% convertible senior unsecured debentures on August 19, 2026. Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - WELL Health Techno...
WELL Health Technologies Q2 Earnings Call Highlights
WELL Health Technologies TSE: WELL reported second-quarter revenue of approximately C$404 million, up 12% from a year earlier, while adjusted EBITDA was C$48.1 million, down 3% on a reported basis. Th...
WELL Health Technologies Earnings Call Transcript: Q2 2026
Q2 2026 saw strong revenue growth, margin expansion, and early achievement of key profitability milestones, driven by acquisitions and tech enablement. Guidance for 2026 was raised, with WELLSTAR's public listing and strategic M&A supporting future growth.
WELL Health Technologies Earnings release: Q2 2026
WELL Health Technologies released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
WELL Health Technologies MD&A: Q2 2026
WELL Health Technologies filed a regulatory document on August 6, 2026 disclosing important business information.
WELL Health Technologies Report: Q2 2026
WELL Health Technologies published a report on August 6, 2026 containing material business information for investors and shareholders.
WELL Health Technologies Slides: Q2 2026
WELL Health Technologies has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance
WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly re...
Well Health price target raised to C$8.50 from C$8.25 at Stifel
Stifel raised the firm’s price target on Well Health (WHTCF) to C$8.50 from C$8.25 and keeps a Buy rating on the shares.
WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer
WELL appoints accomplished legal and business executive Loreto Grimaldi as Chief Legal Officer to lead legal, compliance, governance, risk management and M&A activities across the organization. Season...
WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026
Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively...
WELL Health Subsidiary WELLSTAR Closes C$50 Million Financing Transaction Ahead of Planned TSXV Listing
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outc...
WELL Health Closes $150 Million, 5-Year Senior Unsecured Notes Offering
Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impa...
WELL Health Announces Pricing of $150 Million Senior Unsecured Notes Offering
WELL has priced its inaugural offering of $150 million of senior unsecured notes due 2031, bearing interest at 6.875% per annum. Net proceeds will be used to fully repay WELL's convertible debentures ...
WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada's Leading Healthcare Software and AI Platforms
Not for distribution to United States news wire services or for dissemination in the United States. WELLSTAR is expected to become a publicly listed company through a TSXV listing, supported by a Conc...
WELL Health Announces Voting Results for Election of Directors
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impa...
WELL Health Provides a Corporate Update on Circle Medical
WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States....
WELL Health Strengthens Clinical and Public Sector Leadership with Appointment of Dr. Andrew Bond as Chief Health Officer and Head of Public Sector
WELL appoints accomplished physician executive and health system leader Dr. Andrew Bond as Chief Health Officer and Head of Public Sector to lead clinical governance and performance, government relati...